- Report
- February 2024
- 120 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Report
- April 2024
- 181 Pages
Global
From €4733EUR$4,900USD£4,047GBP
- Report
- November 2023
- 190 Pages
Global
From €4733EUR$4,900USD£4,047GBP
- Report
- August 2023
- 215 Pages
Global
€4632EUR$4,795USD£3,961GBP
- Report
- October 2023
- 81 Pages
Global
From €1444EUR$1,495USD£1,235GBP
- Conference
- May 2024
- 2 Days
Global
€1364EUR$1,462USD£1,127GBP
- Report
- April 2024
- 185 Pages
Global
From €4733EUR$4,900USD£4,047GBP
- Report
- June 2023
Global
From €1449EUR$1,500USD£1,239GBP
- Report
- December 2022
- 142 Pages
Global
From €1834EUR$1,899USD£1,569GBP
- Report
- April 2022
- 334 Pages
Global
From €4636EUR$4,799USD£3,964GBP
- Report
- February 2020
- 328 Pages
Global
From €4732EUR$4,899USD£4,047GBP
- Report
- June 2018
- 315 Pages
Global
From €3380EUR$3,499USD£2,890GBP
- Report
- February 2022
- 265 Pages
Global
From €3622EUR$3,750USD£3,097GBP
- Report
- September 2019
- 142 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- November 2020
- 382 Pages
Global
From €4782EUR$4,950USD£4,089GBP
- Report
- January 2022
- 115 Pages
Global
From €2415EUR$2,500USD£2,065GBP
- Report
- March 2020
- 155 Pages
Global
From €1328EUR$1,375USD£1,136GBP
€2656EUR$2,750USD£2,271GBP
- Report
- December 2019
- 196 Pages
Global
From €1328EUR$1,375USD£1,136GBP
€2656EUR$2,750USD£2,271GBP
- Report
- January 2019
- 214 Pages
Global
From €1328EUR$1,375USD£1,136GBP
€2656EUR$2,750USD£2,271GBP
- Report
- December 2021
- 377 Pages
Global
From €3622EUR$3,750USD£3,097GBP
The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more